Ligand Pharmaceuticals Incorporated (LGND)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 85.05 |
| Open | 85.44 |
| Bid | 87.68 x 100 |
| Ask | 87.99 x 100 |
| Day's range | 85.29 - 88.73 |
| 52-week range | 49.24 - 94.57 |
| Volume | |
| Avg. volume | 169,920 |
| Market cap | 1.579B |
| Beta (5Y monthly) | 0.92 |
| PE ratio (TTM) | 16.40 |
| EPS (TTM) | 5.36 |
| Earnings date | 06 Aug 2024 - 12 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 02 Jul 2010 |
| 1y target est | 116.80 |
Business WireLigand to Participate in Upcoming Investor Conferences
JUPITER, Fla., May 23, 2024--Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that Todd Davis (Chief Executive Officer) and Tavo Espinoza (Chief Financial Officer) will participate in the following upcoming investor conferences:
ZacksAstraZeneca (AZN) Plans to Generate $80B in Revenues by 2030
AstraZeneca (AZN) targets $80 billion in total revenues by 2030. It expects to launch 20 new medicines.
ZacksDyne (DYN) Soars 28% on New Data From Muscle Disease Studies
Dyne (DYN) gains 28% after reporting positive new data from two separate ongoing mid to late-stage studies evaluating DYNE-101 and DYNE-251 for different muscle disease indications.
© 2024 Yahoo. All rights reserved.